Study supports efficacy and safety of lung-selective nanotherapy against SARS-CoV-2 infection

By | October 8, 2021
A new preprint shows the potential role of a host protease cathepsin L inhibitor, which mediates viral entry into the host cell by its effect on the viral spike protein.